Best Peptides for Post-COVID Recovery

Post-acute COVID-19 syndrome (long COVID) encompasses persistent symptoms—including fatigue, cognitive dysfunction, and respiratory challenges—that extend weeks to months after initial infection, often involving dysregulated immune responses and lingering inflammation. Research peptides like Thymosin Alpha-1 are being investigated for their potential to restore T-cell function and normalize immune signaling, as evidence suggests long COVID involves impaired cellular immunity and aberrant cytokine production that may benefit from immune system modulation.

Research protocols for immune-modulating peptides in post-COVID contexts typically involve subcutaneous or intramuscular administration on variable schedules, ranging from daily to weekly dosing depending on study design and therapeutic goals. Timing relative to symptom onset and individual immune status may influence protocol design, though standardized dosing regimens for this indication remain under investigation.